IROQ stock is currently trading at $18.00, down 29.4% in pre-market trading, likely due to weak Q3 2024 earnings with EPS of $0.22 and revenue of $5.40M, which may have disappointed investors. Bulls might argue that the stock is undervalued after this sharp drop, presenting a potential rebound opportunity if the company improves its financial performance. However, the lack of strong growth catalysts in the near term makes this a speculative play.